Prevalence and Determinants of a Blunted Parathyroid Hormone Response in Young Saudi Women with Vitamin D Deficiency: A Cross-Sectional Study

Al Kadi, Hanan

doi:https://doi.org/10.1155/2021/5579484

International Journal of Endocrinology

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2021 | Article ID 5579484 | https://doi.org/10.1155/2021/5579484

Prevalence and Determinants of a Blunted Parathyroid Hormone Response in Young Saudi Women with Vitamin D Deficiency: A Cross-Sectional Study

Hanan Al Kadi¹

Academic Editor: Muhammad Shahab

Received23 Jan 2021

Revised20 Aug 2021

Accepted08 Sept 2021

Published18 Sept 2021

Abstract

Vitamin D deficiency is highly prevalent among the Saudi population. Increased parathyroid hormone (PTH) secretion is an appropriate homeostatic response to correct the resultant hypocalcemia. However, not all vitamin D deficiency patients have increased PTH levels. This study determined the prevalence of a blunted PTH response to vitamin D deficiency among apparently healthy young Saudi women and assessed anthropometric and biochemical factors associated with this response by performing a secondary analysis of data obtained from a cross-sectional study conducted at the “Center of Excellence for Osteoporosis research.” Overall, 315 women (aged 20–45 years) with vitamin D deficiency (serum 25-hydroxyvitamin D (25(OH)D) levels <30 nmol/L) were included. They were divided into two groups according to the laboratory cutoff value of PTH (<7 or ≥7 pmol/L), and anthropometric and biochemical characteristics of both groups were compared. Women with a blunted PTH response (n = 62, 19.7%) had a significantly lower body mass index (BMI) () and smaller waist circumference (). They also had significantly higher serum 25(OH)D (), corrected serum calcium (), and phosphate () levels than those with an elevated PTH response (n = 253, 80.3%). Multiple logistic regression analysis showed that lower BMI (OR = 0.925; 95% CI: 0.949–0.987) and higher 25(OH)D (OR = 1.068; 95% CI: 1.014–1.124) and serum calcium (OR = 8.600; 95% CI: 1.614–45.809) levels were significantly associated with a blunted PTH response (R² = 0.178). A blunted PTH response to vitamin D deficiency is mainly observed among women with lower BMI. Higher serum calcium and 25(OH)D levels and lower BMI were significant predictors of a blunted PTH response, which may indicate that these subjects are adapting to lower 25(OH)D levels and maintaining normal calcium levels without the need to increase PTH secretion. The mechanisms underlying this adaptation are unclear, and future studies to explore these mechanisms are warranted.

1. Introduction

Vitamin D deficiency is a widespread health problem among women living in Jeddah, Saudi Arabia. [1, 2]. The active form of vitamin D (1,25-dihydroxycholecalciferol) stimulates calcium absorption from the gut; thus, vitamin D deficiency leads to malabsorption of dietary calcium, leading to hypocalcemia. The appropriate homeostatic response to hypocalcemia is increased parathyroid hormone (PTH) secretion from the parathyroid glands. However, not all women exhibit this increase in PTH levels. This blunted PTH response has been termed “functional hypoparathyroidism” [3]. This blunted response has been explained by different mechanisms, including low plasma magnesium level [4, 5], high dietary calcium intake [6], local adaptive mechanisms regulating intestinal calcium absorption (independently of vitamin D and PTH secretion), the so-called “intestinal calcistat” [7], and diurnal variations in PTH secretion [8]. Postmenopausal women with functional hypoparathyroidism exhibit higher bone mineral density than women with an elevated PTH response and, hence, may have lower fracture risks [9]. This is expected as PTH exerts an osteoclastic function on the bone [10] to correct hypocalcemia secondary to vitamin D deficiency. To the best of our knowledge, there are no data on the pattern of the PTH response among young women with vitamin D deficiency living in Jeddah, Saudi Arabia. Therefore, this study determined the prevalence of a blunted PTH response among otherwise healthy young Saudi women with vitamin D deficiency and assessed its associated anthropometric and biochemical factors.

2. Materials and Methods

The current analyses were performed with data of women who participated in a cross-sectional study for the assessment of bone health at the “Center of Excellence for Osteoporosis research” (CEOR), Jeddah, Saudi Arabia. Details of the study design, recruitment, and data collection protocol have been described previously [11]. In brief, women were randomly recruited from 40 primary health care centers in Jeddah. Those willing to participate in the study were invited to visit the CEOR, complete a validated questionnaire, and undertake all the anthropometric and biochemical measurements. A subgroup comprising 315 women (aged 20–45 years) with serum 25(OH)D levels <30 nmol/L (vitamin D deficiency) [12, 13] was selected for this analysis (Figure 1).

All women who were included had no chronic diseases and were not on any long-term medications. Pregnant women were excluded. The weight, height, and waist circumference (WC) were measured in kg, cm, and cm, respectively. The body mass index (BMI, kg/m²) was calculated by dividing the weight by the square of the height in meters. Fasting blood samples were collected to determine 25(OH)D and PTH levels (in nmol/L and pmol/L, respectively). Both were determined by direct competitive chemiluminescence immunoassays using the LIAISON autoanalyzer (DiaSorin Inc, Stillwater, MN, USA). Other biochemical parameters (serum creatinine, total calcium, inorganic phosphate, magnesium, and albumin levels) were determined using the Vitros250 Chemistry Auto analyzer (Ortho Clinical Diagnostics, Johnson & Johnson Co., USA). The corrected total calcium concentration was calculated using the formula put forth by Payne et al.: “adjusted calcium concentration (mmol/L) = total calcium concentration (mmol/L) + 0.02 (40−serum albumin concentration (g/L))” [14]. Written informed consent was obtained from all participants, and the study was conducted as per the Declaration of Helsinki. This study was approved by the ethics committee of the CEOR.

2.1. Statistical Analysis

The distribution of the variables was assessed for normality using the Shapiro–Wilk test. All variables were not normally distributed except serum albumin. Continuous data are presented as medians (interquartile ranges) or means ± standard deviations according to the variable distribution. Categorical variables are presented as frequencies and percentages. Using the laboratory cutoff value for PTH, women were split into two groups: group 1—with a PTH concentration <7 pmol/L (blunted PTH response)—and group 2—with a PTH concentration ≥7 pmol/L (elevated PTH response). The two groups were compared with respect to different anthropometric and biochemical variables using the Mann–Whitney or Student’s t-test depending on variable distribution. Spearman’s correlation was used to determine the correlation between different variables. The chi-square test was performed to determine univariate associations between categorical variables. Multiple logistic regression analysis (via the enter method) was performed to examine the determinants of the blunted PTH response. Nagelkerke’s R² was reported to provide information about the explanatory ability of the model; odds ratios (OR) and their 95% confidence intervals (CI) were also provided. Statistical analyses were performed using SPSS version 20 (IBM Corp., Armonk, N.Y., USA). A value <0.05 was considered statistically significant.

3. Results

This analysis included 315 women with vitamin D deficiency. A blunted PTH response (functional hypoparathyroidism) was prevalent among 19.7% (n = 62) of the women studied, while 80.3% (n = 253) exhibited an elevated PTH response. Thirty-five percent of the participants (n = 109) had severe vitamin D deficiency (25(OH)D level <12.5 nmol/L). The characteristics of the study participants are presented in Table 1. The differences in anthropometric and biochemical characteristics between women with a blunted PTH response and those with an elevated PTH response are also presented in Table 1.

Women in the blunted PTH response group were significantly younger (); had significantly lower BMI () and WC (); and had higher 25(OH)D (), calcium (), and phosphate () levels than those with an elevated PTH response. There were no significant differences concerning serum magnesium or creatinine levels. Figure 2 shows the two groups according to the BMI category. The majority of women with obesity (88.9%) were categorized in the group with an elevated PTH response (Χ² = 7.512, ).

Table 2 shows the correlation coefficients between the different variables among all women with 25(OH)D deficiency (n = 315). There was a statistically significant inverse correlation between PTH and 25(OH)D, corrected total serum calcium, and inorganic phosphate levels ( for all correlations), and a positive correlation between age () and measures of adiposity (BMI and WC) ( for both correlations).

Table 3 shows the results of the multivariable logistic regression analysis. The most significant variables, which were independently associated with a blunted PTH response, were higher corrected total serum calcium levels (OR = 8.600; 95% CI: 1.614–45.809), higher 25(OH)D levels (OR = 1.068; 95% CI: 1.014–1.124), and lower BMI (OR = 0.925; 95% CI: 0.949–0.987), as indicated by the odds ratio, with an R² = 0.178.

4. Discussion

This study confirmed the previously described condition of “functional hypoparathyroidism,” in which a blunted PTH response is observed in some subjects, despite low 25(OH)D levels [9, 15–17]. The prevalence rate of a blunted PTH response was almost 20%, which was lower than that reported in other studies [16, 18–20], most of which defined vitamin D deficiency as a 25(OH)D level <50 nmol/L which is higher than the cutoff value used in this study (<30 nmol/L), and hence, the probability of a normal PTH level was higher. Moreover, several of these studies included older participants and postmenopausal women of different ethnic origins. PTH levels are known to increase with age [21], and ethnic differences in PTH secretion have been previously documented [22]. Therefore, it would be difficult to directly compare different studies of patients of different ethnic origins.

Higher serum calcium and 25(OH) D levels were the main determinants among participants with a blunted PTH response. These results may imply that these women could maintain calcium homeostasis despite the low 25(OH)D levels and without stimulating the parathyroid glands. One possible mechanism that was postulated by Garg is the so-called “intestinal calcistat” [7], which suggests a local mechanism whereby the body first adapts to increased “fractional calcium absorption” in the presence of low vitamin D status, independent of PTH secretion. If this local adaptation fails, secondary hyperparathyroidism ensues.

A low BMI was another predictor of a blunted PTH response. This agrees with the results of most studies that reported a direct relationship between increased adiposity and higher PTH levels [9, 15]. In this study, BMI was positively correlated with PTH but not 25(OH)D levels. Vitamin D deficiency is more prevalent among subjects with obesity [23] due to the sequestration of the fat-soluble vitamin D in fat stores, which reduces the bioavailability of 25(OH)D [24]. However, a previous study suggested that there exists a relationship between obesity and high PTH levels independent of the vitamin D status [25]. This is supported by the observation that PTH increases intracellular calcium levels [26], resulting in the inhibition of lipolysis in fat cells [27]. Therefore, lower PTH levels are expected to be associated with lower BMI in subjects without obesity. In fact, almost 90% of the subjects with obesity in this study belonged to the elevated PTH response group (Figure 2).

Magnesium deficiency is a well-documented cause of a blunted PTH response as it inhibits PTH synthesis and secretion [4, 5]. In this study, there was no statistically significant difference in serum magnesium levels between the two groups. However, serum magnesium level is not the best estimate of the tissue concentration of magnesium. The magnesium loading test would be the optimum measure, but it was not performed in this study.

Lower PTH levels were observed among female smokers [15], but this was not the case in the present analysis, probably owing to the low number of women who smoked (5.7%). In this study, smoking status was not associated with the PTH response in the multivariate analysis.

Kidney function is known to affect PTH levels [17]; however, serum creatinine was not independently associated with the PTH response in this study. This is probably because the cohort studied was healthy women with normal serum creatinine levels.

A major limitation of this study includes its cross-sectional design, which prevented the deduction of any causality. Moreover, data on the nutritional intake of calcium were not obtained. However, a study conducted on healthy adults (age, 30–85 years) in Iceland with variable calcium intake (from <800 mg/day to >1200 mg/day) showed that subjects on high calcium intake (>1200 mg/day) did not have optimal serum PTH levels when vitamin D status was insufficient, whereas those with lower calcium intake (<800 mg/day) had ideal PTH levels if their vitamin D status was sufficient [28].

Another limitation was the use of corrected calcium levels rather than the ionized calcium levels, which is the form sensed by the calcium-sensing receptors on the parathyroid glands to increase or decrease PTH secretion accordingly. Magnesium deficiency among those with a blunted PTH response cannot be ruled out as the magnesium loading test, which may have better reflected body stores, was not performed.

The strength of this study stems from studying young women as PTH levels are known to increase with age [21]. All women studied were apparently healthy with normal renal function and not on any medications, which minimized confounding factors affecting PTH levels.

5. Conclusions

The results of this study suggest that a blunted PTH response to vitamin D deficiency is mainly observed in women with lower BMI, higher serum calcium levels, and higher 25(OH)D levels. This may indicate that these subjects are adapting to the lower 25(OH)D levels and maintaining normal calcium levels without the need to increase PTH secretion. The mechanisms underlying this adaptation are not clear, and future studies to explore these mechanisms are warranted. Future studies are also needed to confirm these findings and determine other factors that affect the relationship between vitamin D and PTH levels. It is debatable whether these women should be categorized as vitamin D deficient and receive supplementation, particularly if calcium homeostasis is maintained without increased PTH levels.

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Conflicts of Interest

The author declares that there are no conflicts of interest regarding the publication of this paper.

Acknowledgments

The author is grateful to all the subjects who kindly participated in this study and all the staff at CEOR, especially the laboratory technicians for running the blood tests. The author would also like to thank Editage (http://www.editage.com) for editing and reviewing this manuscript for the English language. This research was funded by the “Centre of Excellence for Osteoporosis Research” (CEOR), King Abdulaziz University, Jeddah, Saudi Arabia.

References

M.-S. M. Ardawi, M. H. Qari, A. A. Rouzi, A. A. Maimani, and R. M. Raddadi, “Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre-and postmenopausal women,” Osteoporosis International, vol. 22, no. 2, pp. 463–475, 2011.
View at: Publisher Site | Google Scholar
I. M. Kaddam, A. M. Al-Shaikh, B. A. Abaalkhail et al., “Prevalence of vitamin D deficiency and its associated factors in three regions of Saudi Arabia,” Saudi Medical Journal, vol. 38, no. 4, pp. 381–390, 2017.
View at: Publisher Site | Google Scholar
O. Sahota, K. Gaynor, R. H. Harwood, and D. J. Hosking, “Hypovitaminosis D and functional hypoparathyroidism’—the NoNoF (Nottingham neck of femur) study,” Age and Ageing, vol. 30, no. 6, pp. 467–472, 2001.
View at: Publisher Site | Google Scholar
R. K. Rude, S. B. Oldham, and F. R. Singer, “Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency,” Clinical Endocrinology, vol. 5, no. 3, pp. 209–224, 1976.
View at: Publisher Site | Google Scholar
O. Sahota, M. K. Mundey, P. San, I. M. Godber, and D. J. Hosking, “Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency,” Osteoporosis International, vol. 17, no. 7, pp. 1013–1021, 2006.
View at: Publisher Site | Google Scholar
P. Patel, M. Z. Mughal, P. Patel et al., “Dietary calcium intake influences the relationship between serum 25-hydroxyvitamin D3 (25OHD) concentration and parathyroid hormone (PTH) concentration,” Archives of Disease in Childhood, vol. 101, no. 4, pp. 316–319, 2016.
View at: Publisher Site | Google Scholar
M. K. Garg, “The intestinal calcistat,” Indian Journal of Endocrinology & Metabolism, vol. 17, pp. S25–S28, 2013.
View at: Publisher Site | Google Scholar
W. D. Fraser, A. M. Ahmad, and J. P. Vora, “The physiology of the circadian rhythm of parathyroid hormone and its potential as a treatment for osteoporosis,” Current Opinion in Nephrology & Hypertension, vol. 13, no. 4, pp. 437–444, 2004.
View at: Publisher Site | Google Scholar
L. Rejnmark, P. Vestergaard, C. Brot, and L. Mosekilde, “Parathyroid response to vitamin D insufficiency: relations to bone, body composition and to lifestyle characteristics,” Clinical Endocrinology, vol. 69, no. 1, pp. 29–35, 2008.
View at: Publisher Site | Google Scholar
D. Goltzman, M. Mannstadt, and C. Marcocci, “Physiology of the calcium-parathyroid hormone-vitamin D axis,” Frontiers of Hormone Research, vol. 50, pp. 1–13, 2018.
View at: Publisher Site | Google Scholar
M.-S. M. Ardawi, H. A. Al-Kadi, A. A. Rouzi, and M. H. Qari, “Determinants of serum sclerostin in healthy pre-and postmenopausal women,” Journal of Bone and Mineral Research, vol. 26, no. 12, pp. 2812–2822, 2011.
View at: Publisher Site | Google Scholar
C. T. Sempos, A. C. Heijboer, D. D. Bikle et al., “Vitamin D assays and the definition of hypovitaminosis D: results from the first international conference on controversies in vitamin D,” British Journal of Clinical Pharmacology, vol. 84, no. 10, pp. 2194–2207, 2018.
View at: Publisher Site | Google Scholar
A. M. AlQuaiz, M. Mujammami, A. Kazi et al., “Vitamin D cutoff point in relation to parathyroid hormone: a population based study in Riyadh city, Saudi Arabia,” Archives of Osteoporosis, vol. 14, no. 1, p. 22, 2019.
View at: Publisher Site | Google Scholar
R. B. Payne, A. J. Little, R. B. Williams, and J. R. Milner, “Interpretation of serum calcium in patients with abnormal serum proteins,” BMJ, vol. 4, no. 5893, pp. 643–646, 1973.
View at: Publisher Site | Google Scholar
Ö. Gunnarsson, Ó. S. Indridason, L. Franzson, and G. Sigurdsson, “Factors associated with elevated or blunted PTH response in vitamin D insufficient adults,” Journal of Internal Medicine, vol. 265, no. 4, pp. 488–495, 2009.
View at: Publisher Site | Google Scholar
S. Kannan, S. Mahadevan, P. Velayutham et al., “Estimation of magnesium in patients with functional hypoparathyroidism,” Indian Journal of Endocrinology and Metabolism, vol. 18, no. 6, pp. 821–825, 2014.
View at: Publisher Site | Google Scholar
S. Patel, S. Hyer, and J. Barron, “Glomerular filtration rate is a major determinant of the relationship between 25-hydroxyvitamin D and parathyroid hormone,” Calcified Tissue International, vol. 80, no. 4, pp. 221–226, 2007.
View at: Publisher Site | Google Scholar
A. Valcour, F. Blocki, D. M. Hawkins, and S. D. Rao, “Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels,” Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 11, pp. 3989–3995, 2012.
View at: Publisher Site | Google Scholar
M. K. Garg, N. Tandon, R. K. Marwaha, A. S. Menon, and N. Mahalle, “The relationship between serum 25-hydroxy vitamin D, parathormone and bone mineral density in Indian population,” Clinical Endocrinology, vol. 80, no. 1, pp. 41–46, 2014.
View at: Publisher Site | Google Scholar
O. Sahota, M. K. Mundey, P. San, I. M. Godber, N. Lawson, and D. J. Hosking, “The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis,” Bone, vol. 35, no. 1, pp. 312–319, 2004.
View at: Publisher Site | Google Scholar
Y. Jiang, L. Liao, J. Li, L. Wang, and Z. Xie, “Older age is associated with decreased levels of VDR, CYP27B1, and CYP24A1 and increased levels of PTH in human parathyroid glands,” International Journal of Endocrinology, vol. 2020, Article ID 7257913, 6 pages, 2020.
View at: Publisher Site | Google Scholar
L. Yan, I. Schoenmakers, B. Zhou et al., “Ethnic differences in parathyroid hormone secretion and mineral metabolism in response to oral phosphate administration,” Bone, vol. 45, no. 2, pp. 238–245, 2009.
View at: Publisher Site | Google Scholar
M. Pereira-Santos, P. R. F. Costa, A. M. O. Assis, C. A. S. T. Santos, and D. B. Santos, “Obesity and vitamin D deficiency: a systematic review and meta-analysis,” Obesity Reviews, vol. 16, no. 4, pp. 341–349, 2015.
View at: Publisher Site | Google Scholar
J. Wortsman, L. Y. Matsuoka, T. C. Chen, Z. Lu, and M. F. Holick, “Decreased bioavailability of vitamin D in obesity,” American Journal of Clinical Nutrition, vol. 72, no. 3, pp. 690–693, 2000.
View at: Publisher Site | Google Scholar
M. J. Bolland, A. B. Grey, G. D. Gamble, and I. R. Reid, “Association between primary hyperparathyroidism and increased body weight: a meta-analysis,” Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 3, pp. 1525–1530, 2005.
View at: Publisher Site | Google Scholar
Z. Ni, M. Smogorzewski, and S. G. Massry, “Effects of parathyroid hormone on cytosolic calcium of rat adipocytes,” Endocrinology, vol. 135, no. 5, pp. 1837–1844, 1994.
View at: Publisher Site | Google Scholar
B. Xue, A. G. Greenberg, F. B. Kraemer, and M. B. Zemel, “Mechanism of intracellular calcium ([Ca²⁺]_i) inhibition of lipolysis in human adipocytes,” The FASEB Journal, vol. 15, no. 13, pp. 2527–2529, 2001.
View at: Publisher Site | Google Scholar
L. Steingrimsdottir, O. Gunnarsson, O. S. Indridason, L. Franzson, and G. Sigurdsson, “Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake,” Journal of the American Medical Association, vol. 294, no. 18, pp. 2336–2341, 2005.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2021 Hanan Al Kadi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

270

Downloads

518

Citations